Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision history adds v3.3.2 and removes v3.3.1, which appear to be site versioning updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe record history shows a new revision (v3.3.1) on 2025-11-19 with an added 'Study Status' entry, replacing the prior revision (v3.2.0) dated 2025-07-03. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check29 days agoChange DetectedRemoved the general government funding/operating status notice from the page; the status guidance remains available via cc.nih.gov and opm.gov. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedThe new screenshot shows an updated version history list and minor layout changes to the Record History page.SummaryDifference0.0%

- Check71 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference8%

- Check79 days agoChange Detected- Page revision updated from v3.0.2 to v3.1.0. - No other content, pricing, or stock changes detected.SummaryDifference0.2%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.